GERM 0.00 ETFMG Treatments, Testing and Advancements ETF
| Range: | 16.32-20.1994 | Vol Avg: | 1202 | Last Div: | 0.2 | Changes: | -0.06 |
| Beta: | 1.02 | Cap: | 0.01B | Currency: | USD | Exchange: | AMEX |
| Sector: | Financial Services | IPO: | Thu Jun 18 2020 | Empoloyees: | |||
| CUSIP: | CIK: | 0001467831 | ISIN: | US0321085815 | Country: | US | |
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow